| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Eterna Therapeutics Inc. | General Counsel, Director | Stock Option (right to buy) | 168,521 | 01 Jan 2024 | Direct | ||
| Comera Life Sciences Holdings, Inc. | Director | Stock Option (Right to Purchase | 14,200 | 07 Nov 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ERNA | Eterna Therapeutics Inc. | 01 Jan 2024 | 1 | $0 | 4 | General Counsel, Director | 03 Jan 2024, 17:01 |
| /report/000106299323020478-clarke-dorothy-j-2023-11-07 | Comera Life Sciences Holdings, Inc. | 07 Nov 2023 | 1 | $0 | 4 | Director | 13 Nov 2023, 06:31 |
| /report/000106299323020477-clarke-dorothy-j-2023-11-07 | Comera Life Sciences Holdings, Inc. | 07 Nov 2023 | 0 | $0 | 3 | Director | 13 Nov 2023, 06:30 |
| ERNA | Eterna Therapeutics Inc. | 28 Aug 2023 | 0 | $0 | 3 | Director | 01 Sep 2023, 18:00 |